Dyfyniad APA

Scott, S., Libby, C., & Hjelmeland, A. (2018). DDIS-15. A NOVEL DOPAMINE RECEPTOR 3 ANTAGONIST INHIBITS THE GROWTH OF PRIMARY AND TEMOZOLOMIDE RESISTANT GLIOBLASTOMA CELLS. Neuro Oncol.

Dyfyniad Arddull Chicago

Scott, Sarah, Catherine Libby, and Anita Hjelmeland. "DDIS-15. A NOVEL DOPAMINE RECEPTOR 3 ANTAGONIST INHIBITS THE GROWTH OF PRIMARY AND TEMOZOLOMIDE RESISTANT GLIOBLASTOMA CELLS." Neuro Oncol 2018.

Dyfyniad MLA

Scott, Sarah, Catherine Libby, and Anita Hjelmeland. "DDIS-15. A NOVEL DOPAMINE RECEPTOR 3 ANTAGONIST INHIBITS THE GROWTH OF PRIMARY AND TEMOZOLOMIDE RESISTANT GLIOBLASTOMA CELLS." Neuro Oncol 2018.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.